• Publications
  • Influence
The diagnosis and management of acute and chronic urticaria: 2014 update.
TLDR
These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology, representing the AAAAI, the ACAAI, and the Joint Council of All allergy, asthma and Immunology. Expand
Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women.
TLDR
COPD may be a risk factor for developing type 2 diabetes, and differences in the inflammation and cytokine profile between COPD and asthma might explain why COPD, but not asthma, is associated with increased risk of type 1 diabetes. Expand
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
TLDR
This study, the largest clinical analysis of patients with HES to date, provides useful information for clinicians but also should stimulate prospective trials to optimize treatment of HES. Expand
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
TLDR
An updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement, and the evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EOE than as a diagnostic criterion. Expand
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.
TLDR
These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology, representing the AAAAI, the ACAAI, and the Joint Council of All allergy, asthma and Immunology. Expand
Hypereosinophilic syndromes: A multicenter, retrospective analysis of clinical characteristics and response to therapy
Background—Hypereosinophilic syndromes (HES) are a heterogeneous group of rare disorders defined by persistent blood eosinophilia ≥1.5 × 109/L, absence of a secondary cause, and evidence ofExpand
Clinical overview of hypereosinophilic syndromes.
TLDR
Recent evidence suggests that, in addition to differences in clinical features, the range of complications, treatment options, and prognoses differs significantly among the myeloproliferative, lymphocytic, and undefined variants of HES. Expand
Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome).
TLDR
It is hoped that this review will be of help to those readers who care for patients with patients with angioedema, and will stimulate interest in further research into the pathophysiology of these conditions. Expand
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
TLDR
The frequency of TA in patients with CIU was 30%, which is higher than that previously reported and higher in females than in males, and there was no correlation between BAT-CD203 and TA. Expand
Angioedema deaths in the United States, 1979-2010.
TLDR
Angioedema-associated deaths were very rare from 1979 to 2010, whereas nonhereditary angIOedema deaths increased, indicating that more granular coding systems may help distinguish hereditary from acquired angioingema. Expand
...
1
2
3
4
5
...